1999
DOI: 10.1001/jama.282.2.153
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of Carpal Tunnel Syndrome in a General Population

Abstract: Symptoms of pain, numbness, and tingling in the hands are common in the general population. Based on our data, 1 in 5 symptomatic subjects would be expected to have CTS based on clinical examination and electrophysiologic testing.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

54
1,026
12
78

Year Published

1999
1999
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 1,652 publications
(1,170 citation statements)
references
References 19 publications
54
1,026
12
78
Order By: Relevance
“…The syndrome affects an estimated 2.7% of the population [2,3,7,8,13]. Overall prevalence of CTS in the United States may affect as many as 1.9 million people and may account for 500,000 surgical procedures annually, with costs over $2 billion [12].…”
Section: Introductionmentioning
confidence: 99%
“…The syndrome affects an estimated 2.7% of the population [2,3,7,8,13]. Overall prevalence of CTS in the United States may affect as many as 1.9 million people and may account for 500,000 surgical procedures annually, with costs over $2 billion [12].…”
Section: Introductionmentioning
confidence: 99%
“…CTS is progressive and produces numbness, pain, swelling, and weakness of hands, causing significant inconvenience for patients. The prevalence of CTS has been reported from 1 to 3 % in a general population [1], and there is some evidence indicating that the incidence of CTS is increasing [2]. Moreover, about 400,000 procedures of carpal tunnel release, which is the most common hand and wrist surgery, are performed in the USA per year [2].…”
Section: Introductionmentioning
confidence: 99%
“…The prevalence of this disorder has been estimated between one and five percent in the general population [1][2][3] with higher estimated rates of 10% or more reported among workers in some industries [4][5][6]. The direct costs for treatment and indirect costs for lost work time and permanent functional disability make this syndrome costly for patients as well as employers [7,8].…”
Section: Introductionmentioning
confidence: 99%